Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| BMY | Bristol-Myers Squibb Company | -0.61% | 45.52 | 1.4% | $885.56m | |
| JNJ | Johnson & Johnson | -0.74% | 137.49 | 0.7% | $815.16m | |
| MRK | Merck & Co., Inc. | -0.97% | 73.20 | 0.6% | $807.82m | |
| PFE | Pfizer Inc. | -1.25% | 39.38 | 0.9% | $798.16m | |
| LLY | Eli Lilly and Company | -1.12% | 115.20 | 1.0% | $696.30m | |
| ABBV | AbbVie, Inc. | -0.54% | 77.56 | 2.2% | $385.63m | |
| AZN | AstraZeneca PLC Sponsored ADR | 0.08% | 38.80 | 1.3% | $247.97m | |
| NVS | Novartis AG Sponsored ADR | -1.16% | 76.40 | 0.2% | $242.29m | |
| GSK | GlaxoSmithKline plc Sponsored ADR | -0.30% | 39.86 | 0.2% | $101.53m | |
| NVO | Novo Nordisk A/S Sponsored ADR Class B | -0.25% | 48.39 | 0.1% | $65.24m | |
| SNY | Sanofi Sponsored ADR | 0.54% | 41.31 | 0.2% | $39.69m | |
| LCI | Lannett Company, Inc. | 1.71% | 7.15 | 36.7% | $7.95m | |
| AKTX | Akari Therapeutics Plc Sponsored ADR | 0.32% | 3.12 | 1.6% | $0.76m | |
| EPIX | ESSA Pharma Inc | -9.17% | 2.29 | 0.1% | $0.03m |
Company Profile
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.